tert-butyl (3-amino-3-oxo-1-phenylpropyl)carbamate | 126590-55-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: tert-butyl (3-amino-3-oxo-1-phenylpropyl)carbamate
• 英文别名: tert-butyl N-(2-carbamoyl-1-phenylethyl)carbamate；tert-butyl N-(3-amino-3-oxo-1-phenylpropyl)carbamate
• CAS: 126590-55-4
• 化学式: C₁₄H₂₀N₂O₃
• 分子量: 264.324
• InChiKey: NAEORAQHOXGYSN-UHFFFAOYSA-N

物化性质

• 沸点：
  475.4±45.0 °C(Predicted)
• 密度：
  1.123±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  19
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  81.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  tert-butyl (3-amino-3-oxo-1-phenylpropyl)carbamate 在 吡啶 、 硼烷四氢呋喃络合物 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 24.0h， 生成 tert-butyl (3-((5-(dimethylamino)naphthalene)-1-sulfonamido)-1-phenylpropyl)carbamate
  参考文献：
  名称：

  [EN] PRMT5 INHIBITORS AND USES THEREOF
  [FR] INHIBITEURS DE PRMT5 ET LEURS UTILISATIONS

  摘要：

  公开号：

  WO2015200680A8
• 作为产物：
  描述：

  DL-3-氨基-3-苯基丙酸 在 sodium carbonate 、 N,N'-羰基二咪唑 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 水 为溶剂， 反应 24.5h， 生成 tert-butyl (3-amino-3-oxo-1-phenylpropyl)carbamate
  参考文献：
  名称：

  [EN] PRMT5 INHIBITORS AND USES THEREOF
  [FR] INHIBITEURS DE PRMT5 ET LEURS UTILISATIONS

  摘要：

  公开号：

  WO2015200680A8

文献信息

• Intermolecular Aminocarbonylation of Alkenes using Concerted Cycloadditions of Iminoisocyanates
  作者：Amanda Bongers、Christian Clavette、Wei Gan、Serge I. Gorelsky、Lyanne Betit、Kaitlyn Lavergne、Thomas Markiewicz、Patrick J. Moon、Nicolas Das Neves、Nimrat K. Obhi、Amy B. Toderian、André M. Beauchemin

  DOI：10.1021/acs.joc.6b02713

  日期：2017.1.20

  that the LUMO of the iminoisocyanate is reacting with the HOMO of the alkene. Computational and experimental results support a concerted asynchronous [3 + 2] cycloaddition involving an iminoisocyanate, which was observed for the first time by FTIR under the reaction conditions. The products of this reaction are complex azomethine imines, which are precursors to valuable β-amino carbonyl compounds such

  烯烃的氨基羰基化是访问仍未开发的β-氨基羰基基序的有效方法。在此，提出了亚氨基异氰酸酯与烯烃的分子间氨基羰基化反应性的发展。这包括发现芴酮衍生的试剂，该试剂对许多烯烃类别均有效，并有助于衍生化。富电子的底物最具反应性，这表明亚氨基异氰酸酯的LUMO与烯烃的HOMO反应。计算和实验结果支持涉及亚氨基异氰酸酯的协同异步[3 + 2]环加成反应，这是在反应条件下首次通过FTIR观察到的。该反应的产物是复杂的甲亚胺亚胺，它们是有价值的β-氨基羰基化合物（例如β-氨基酰胺和酯，吡唑啉酮和双环吡唑烷酮）的前体。通过对映选择性还原动力学拆分偶氮甲亚胺（s = 13–43）允许获得对映体富集的产品。总的来说，这项工作提供了一种将烯烃转化为β-氨基羰基化合物的新工具。
• Enantioselective biocatalytic hydrolysis of β-aminonitriles to β-amino-amides using Rhodococcus rhodochrous ATCC BAA-870
  作者：Varsha Chhiba、Moira L. Bode、Kgama Mathiba、Wendy Kwezi、Dean Brady

  DOI：10.1016/j.molcatb.2011.12.005

  日期：2012.4

  A range of beta-aminonitriles (3-amino-3-phenylpropanenitrile and derivatives) were synthesised by reaction of various benzonitriles with acetonitrile and subsequent reduction of the resulting acrylonitrile products. These compounds were hydrolysed to the corresponding amides using the nitrile biocatalytic activity of Rhodococccus rhodochrous ATCC BAA-870. Results showed that the nitrile hydratase enzyme was enantioselective for these compounds, in particular 3-amino-3-p-tolylpropanenitrile and 3-amino-3-(4-methoxyphenyl)propanenitrile and the corresponding amides (up to 85% in one case). The reactions were performed at pH 9.0 after initial attempts at pH 7.0 were unsuccessful, most likely as a result of protonation of the 3-amino group at the lower pH. (C) 2012 Elsevier B.V. All rights reserved.
• New ribofuranuronic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP0071926B1

  公开（公告）日：1986-10-08
• PRMT5 INHIBITORS AND USES THEREOF
  申请人：Epizyme, Inc.

  公开号：US20170198006A1

  公开（公告）日：2017-07-13

  Described herein are compounds of Formula (I)-(XIII), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.
• METHOD FOR SYNTHESIZING NOVEL CHIRAL LIGAND, METAL CHELATE, A VARIETY OF NON-NATURAL AMINO ACIDS, MARAVIROC AND KEY INTERMEDIATE THEREOF
  申请人：SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES

  公开号：US20190233456A1

  公开（公告）日：2019-08-01

  Disclosed is a method for synthesizing a novel chiral ligand, a metal chelate, a variety of non-natural amino acids, Maraviroc and a key intermediate thereof. In the invention, (R)-2-methyl proline is selected and used as a starting raw material, (S)-β 3 -amino acid is obtained by asymmetric resolution induced by using a nickel chelate, and Maraviroc is synthesized by using (S)-3-amino-3-phenylpropionic acid as a key intermediate with a high yield and the ee value reaching 98.2% or more. The method of the present invention has widely available materials, mild synthetic process conditions, is easy to control, and produces a product of a high optical purity.